A recently published single-center cohort study evaluated how bariatric surgery and newer glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide and tirzepatide, affect body composition in routine clinical practice.1 Rather than focusing solely on total weight loss, the study examined changes in fat mass, fat-free mass, and their relative proportions over time.
The study included 3,066 patients and followed outcomes for up to 24 months. Both bariatric surgery and GLP-1 RA treatment were associated with substantial reductions in fat mass and modest losses in fat-free mass. However, the magnitude of fat loss and the resulting improvement in the fat-free mass–to–fat mass ratio were consistently greater among patients who underwent bariatric surgery.
Why Body Composition Matters More Than Weight Alone
Weight loss is often discussed in terms of pounds or BMI, but these measurements don’t tell the full story. From a health perspective, what you lose matters just as much as how much you lose.
- Fat mass (FM) is strongly linked to diabetes, cardiovascular disease, sleep apnea, and many obesity-related conditions.
- Fat-free mass (FFM) includes muscle, bone, organs, and body water. Preserving muscle is essential for metabolism, strength, mobility, and long-term weight maintenance.
A healthier outcome is not simply losing weight—it’s losing a higher proportion of fat while preserving as much muscle as possible. One useful way to assess this is the fat-free mass–to–fat mass ratio. A higher ratio reflects better metabolic health.
About the Study
Researchers analyzed real-world clinical data from 3,066 adults treated at a major academic medical center:
- 1,257 patients underwent bariatric surgery (gastric sleeve or gastric bypass)
- 1,809 patients were treated with GLP-1 medications (semaglutide or tirzepatide)
All patients had repeated body composition measurements over 24 months, allowing researchers to track changes in fat mass, fat-free mass, and their ratio over time.
Key Findings at a Glance
Both approaches were effective—but the magnitude of change was very different.
đź“Š Body Composition Changes Over 24 Months
| Outcome (24 months) | Bariatric Surgery | GLP-1 Medications |
| Fat mass reduction | ~50% | ~18% |
| Fat-free mass reduction | ~12% | ~3% |
| Fat-free mass to fat mass ratio | Higher and sustained | Improved, but lower |
What These Results Mean for Patients
1. Both treatments reduce fat
This study confirms that both bariatric surgery and GLP-1 medications lead to meaningful fat loss. That’s good news, especially for patients who are early in their weight-loss journey or exploring different options.
2. Bariatric surgery leads to substantially greater fat loss
Patients who underwent surgery lost nearly three times more fat than those treated with medications alone. This difference persisted across the full two years of follow-up.
3. Muscle loss was proportionally lower with surgery
While some loss of fat-free mass occurred in both groups (which is expected with weight loss), fat loss greatly outweighed muscle loss, particularly after surgery. As a result, surgical patients achieved a more favorable muscle-to-fat balance.
4. The muscle-to-fat ratio matters
Patients who underwent surgery consistently maintained a higher fat-free mass–to–fat mass ratio, a marker associated with better metabolic health, improved physical function, and lower long-term risk.
A Note on Sex Differences
An important observation from the study was that:
- Men tended to preserve muscle better than women with both treatments
- Women experienced greater relative muscle loss, especially during rapid weight loss
This highlights why personalized strategies—including adequate protein intake, resistance training, and close medical follow-up—are especially important, particularly for female patients.
What This Means When Choosing a Treatment Path
GLP-1 medications are powerful tools and may be appropriate for some patients. However, this study reinforces something we have long observed clinically:
Bariatric surgery remains the most effective treatment for achieving substantial fat loss while improving overall body composition.
For patients with moderate to severe obesity, obesity-related conditions, or long-standing weight struggles, surgery offers:
- Greater and more durable fat loss
- A healthier muscle-to-fat balance
- Proven long-term metabolic benefits
If you are exploring treatment options for obesity, you may request a personalized medical evaluation by submitting your health questionnaire. A qualified bariatric specialist can review your medical history and help determine whether surgical or non-surgical treatment options may be appropriate for you.
Resources
1. Wang Z, Wang L, Zhang X, et al. Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists. JAMA Netw Open. 2026;9(1):e2553323. doi:10.1001/jamanetworkopen.2025.53323
